Viewing Study NCT05657860


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-04-24 @ 8:38 AM
Study NCT ID: NCT05657860
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2022-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Sponsor: Maimonides Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prader-Willi Syndrome View
None Aggression View
None Self-Injurious Behavior View
None Pathologic Processes View
None Behavioral Symptoms View
None Intellectual Disability View
None Neurobehavioral Manifestations View
None Neurologic Manifestations View
None Nervous System Diseases View
None Abnormalities, Multiple View
None Congenital Abnormalities View
None Chromosome Disorders View
None Genetic Diseases, Inborn View
None Obesity View
None Overnutrition View
None Nutrition Disorders View
None Antihypertensive Agents View
None Neurotransmitter Agents View
None Molecular Mechanisms of Pharmacological Action View
None Physiological Effects of Drugs View
None Skin-Picking View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adrenergic alpha-2 Receptor Agonist View
None Guanfacine View
None Adrenergic alpha-Agonists View
None Adrenergic Agonists View
None Adrenergic Agents View